PrecisionLife Selects Gencove for US DNA Wellness Reports

Aug 26, 2026
PrecisionLife has selected Gencove as its US consumer genetics platform partner for DNA wellness reports, starting with a Post COVID report for general wellness and education.

PrecisionLife has selected Gencove as its consumer genetics platform partner to launch DNA wellness reports in the United States, the company announced in a press release.

The partnership will combine Gencove's US sequencing service and at home DNA collection with PrecisionLife's AI powered genomic analysis and reporting platform. Gencove uses low coverage whole genome sequencing for its consumer genomics service.

The first product will be the Post COVID DNA Wellness Report. It will compare an individual's genome with patterns observed in research populations of people known to have long COVID.

The companies said the report is for general wellness and educational purposes only. It is not for clinical use and does not diagnose, detect, predict, prevent, monitor, treat, or manage long COVID or any other medical condition.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.